Skip to main content
. Author manuscript; available in PMC: 2021 Dec 1.
Published in final edited form as: Ann Surg Oncol. 2020 Jun 8;27(13):5248–5256. doi: 10.1245/s10434-020-08558-8

TABLE 2.

Estimated cumulative 5-year cost per patient of melanoma-related treatment

WLE only WLE + SLNB
Baseline model (no systemic therapy) $2480 $10,220
PD-1 antibody* for SLN+ patients $2480 $25,300
PD-1 antibody* for node basin recurrence $12,210 $11,280
PD-1 antibody* for SLN+ or for node basin recurrence $12,210 $26,360
*

Cost of PD-1 antibody based on pembrolizumab dosed Q3 weeks for 1 year